Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: ...

CNBC's Jim Cramer reports on the latest news regarding Moderna.

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

Moderna, Inc.'s stock plummets as challenges mount, including vaccine skepticism, competitive pressures, and the RFK ...

Moderna shares surged further Friday, a day after a senior executive made bullish comments at a healthcare conference about ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...

Moderna (MRNA) stock has fallen 71% over the last six months. While there’s still potential for near-term revenue tailwinds ...

Berenberg has initiated coverage of BioNTech (BNTX) and Moderna (MRNA), citing their leadership positions in mRNA medicine.

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look ...

Jefferies hosted a fireside meeting with Moderna (MRNA) management, where the company noted that COVID vaccines are currently not mandated and ...

Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next ...

Fintel reports that on November 18, 2024, HSBC upgraded their outlook for Moderna (NasdaqGS:MRNA) from Hold to Buy. Analyst ...